Literature DB >> 25209365

Left ventricular function and chronic kidney disease: how soon does it start?

Vito M Campese1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25209365     DOI： 10.1093/ndt/gfu223

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  3 in total

1.  Glucosylceramide synthase inhibition protects against cardiac hypertrophy in chronic kidney disease.

Authors:  Gabriel C Baccam; Jian Xie; Xin Jin; Hyejung Park; Bing Wang; Hervé Husson; Oxana Ibraghimov-Beskrovnaya; Chou-Long Huang
Journal:  Sci Rep       Date:  2022-06-04       Impact factor: 4.996

2.  Cardiorenal syndrome type 4: A study of cardiovascular diseases in chronic kidney disease.

Authors:  Suresh H; Arun B S; Venkatesh Moger; Mallikarjuna Swamy
Journal:  Indian Heart J       Date:  2016-07-15

3.  Left ventricular mass regression, all-cause and cardiovascular mortality in chronic kidney disease: a meta-analysis.

Authors:  Kevin C Maki; Meredith L Wilcox; Mary R Dicklin; Rahul Kakkar; Michael H Davidson
Journal:  BMC Nephrol       Date:  2022-01-16       Impact factor: 2.388
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.